What Pharmacists Need to Know About the 2019-2020 Flu Season
After last year’s drawn-out flu season, the CDC weighs in on what to expect in 2019-2020
How Pharmacists Are Embracing New Technologies
Pharmacies are making the most of tech from automation to big data.
Wilate Approved for Hemophilia A Treatment
Also indciated to control bleeding and perioperative management.
Immunotransplants May Enhance Efficacy of Checkpoint Blockade Immunotherapy for Treating Resistant Lymphomas
Immunotherapy drugs combined with stem cell transplantation.
Combating Low-Grade Lymphomas with Less Toxic Approaches
A look at a new study examining the effects of a pipeline drug.
California Bill Allows Pharmacists to Initiate HIV Medication Without Prescription
A new law gives pharmacists increased authority.
How to Prevent Pharmacist Burnout
Why is pharmacy work so stressful, and how can pharmacists take care of that stress?
Brolucizumab-dbll Approved by FDA for Wet AMD
Injection for leading cause of severe vision loss and legal blindness.
FDA Approves Trifarotene Cream for Acne Treatment
First new treatment of its kind in over 20 years.
Physicians On-board with Herpes Zoster Vaccine
More doctors referring patients to pharmacies for shots.
Enteric Zoster: Hidden Shingles Threat
Characterized by severe abdominal pain.
FDA Approves Second HIV PrEP Treatment
Currently only approved for men and transgender women; future trials expected.
Studies Examining Marijuana and COPD
Whether marijuana use increases COPD susceptibility remains uncertain.
Flu Shot May Be a COPD Lifesaver
Only 50% of COPD patients are estimated to be vaccinated.
The 10 Best-and Worst-States for Vaccinations
Which states are the most likely to vaccinate-and which ones are most likely to skip?
Opinion: The Truth About ARCOS and the Opioid Epidemic
The DEA had access to information about where opioids were being sold, but didn’t act on it. Why?
NIH Awards $945 Million for Opioids Research
“Historic investment” distributed to private companies, universities, and researchers.
FDA, DEA Send Warning to Illegal Opioid Distributors
Controlled substance tramadol among the illegally marketed painkillers.
Biosimilars: Some Call for ‘Cautious Optimism’
Biosimilars may need more time to devleop in the market.
Rituximab Gains First Pediatric Approval
For granulomatosis with microscopic polyangiitis in children.
FDA Approves Canagliflozin Indication Expansion
Now approved for risk reductions in patients with type 2 diabetes mellitus.
Generics of Older Drugs Could Have Saved Medicare Billions, Study Says
Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.
Biosimilars Need Access and Cost Examinations
Biologic medicines could lower spending by $153 billion by 2023.
USP Postponing Chapters 795, 797, and 825
Several pharmacy groups appealed guideline revisions.
The Latest Autoimmune Disease Treatment Advances
Psoriasis, MS, Lupus, and RA.
5 Pipeline Drugs to Watch
A look at some of the exciting drugs that could be approved in the coming months.
FDA Approves Jynneos for Smallpox and Monkeypox in Adults
Will be part of the U.S.’s public health emergency medical supplies and pharmaceuticals.
FDA Urged to Expedite Ranitidine Recalls
Online pharmacy that discovered the impurity discontinues sales.
Unique Offerings Increasing Revenue
Some pharmacies are now serving coffee and other refreshments.
Investigational Guillain-Barré Syndrome Treatment Granted FDA Fast Track Designation
Monoclonal antibody for autoimmune and neurodegenerative disorders.
